JP Morgan Maintains Overweight on PACS Group, Raises Price Target to $58

Benzinga Newsdesk www.benzinga.com Positive 68.5%

Neg 0% Neu 0% Pos 68.5%

JP Morgan analyst Benjamin Rossi maintains PACS Group (NYSE:PACS) with a Overweight and raises the price target from $47 to $58.